Novodx
Tequesta, US · Founded 2022 · Delaware corporation
Find your way into Novodx
Sign up to see every warm intro you have to Novodx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Novodx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
NT

Nancy TorresExecutiveNancy Torres is Executive Officer at Novodx, which has developed GoldN, an at-home diagnostic reader for women's health monitoring.
NT
Nancy Torres KaufmanNamed on SEC filing
Board
MR
Michael RossbachBoard director
MW
Michael WickmanBoard director
BP
Brett ParentBoard director
Reported raises · per SEC filings
Form D private placements$2.3M disclosed across 3 rounds · 2023–2025
▶$200KraisedMar 2025 · 11 investors · Other Health CareRule 506(b)
▶$200KraisedMar 2025 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Nancy TorresExecutive Officer
- Michael WickmanDirector
- Brett ParentDirector
- Michael RossbachDirector
- Christian DanielExecutive Officer
- Offering amount
- $700K
- Amount sold
- $200K
- Minimum investment
- $50K
- Proceeds to insiders
- $700K
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$1.1MraisedFeb 2025 · 11 investors · Other Health CareRule 506(b)
▶$1.1MraisedFeb 2025 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael RossbachDirector
- Christian DanielExecutive Officer
- Michael WickmanDirector
- Brett ParentDirector
- Nancy TorresExecutive Officer
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- Minimum investment
- $4.9K
- Proceeds to insiders
- $1.1M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$1MraisedNov 2023 · 10 investors · Other Health CareRule 506(b)
▶$1MraisedNov 2023 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael RossbachDirector
- Nancy Torres KaufmanExecutive Officer, Director
- Michael WickmanDirector
- Christian DanielExecutive Officer
- Brett ParentDirector
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $10K
- Proceeds to insiders
- $100K
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Novodx raised?
- Novodx has disclosed $2.3M raised across 3 rounds.
- Where is Novodx headquartered?
- Novodx is headquartered in Tequesta, US.